аЯрЁБс>ўџ 35ўџџџ2џџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџьЅСo@№П1bjbj p p ."oo1 џџџџџџˆzzzzzzzŽжжжж, ŽЩ Ж0 2 2 2 2 2 2 $ Rб hV -z™™™V zzƒ ™.zz0 ™0 (Е0 zz|  №ЌuVЁоФжЧ H 0 ™ 0Щ P ,9бІ9| ŽŽzzzz9z| Д Кr,\ˆV V ŽŽ$В$wŽŽВExpression of glycogen synthase kinase-3 (GSK-3) and protein kinase B (Act/PKB) in hippocampus of rats with experimental Alzheimer's disease M. Salkovic-Petrisic*, F. Tribl o, S. Hoyer#, P. Riederero *Department of Pharmacology, Medical School & Croatian Institute for Brain Research, University of Zagreb, Croatia o Department of Clinical Neurochemistry, Clinic of Psychiatry and Psychotherapy, University of Wќrzburg, Germany # Department of Pathology, University of Heidelberg, Germany Objectives. The objective of the study was to investigate the expression of enzymes in insulin signalling cascade, protein kinase B (Act/PKB) and downstream glycogen synthase kinase-3 (GSK-3), in the hippocampus of rats with experimental Alzheimer's disease (streptozotocin /STZ/ intracerebroventricularly /icv/ treated rats). Material and Methods. GSK-3 and Act/PKB were measured by Western blot analysis, one month after the icv administration of STZ (1 mg/kg), as well as after the icv administration of glucose transporter 2 (GLUT2) inhibitor 5-thio-D-glucose (TG; 150 Мg/kg), and their combination (TG+STZ). Cognitive functions were tested by Morris Water Maze Test. Statistical significance was analysed by Kruskal-Wallis ANOVA median test and Mann-Whitney U test, p<0.05. Results. In the STZ group only the expression of phosphorylated GSK form (pGSK) was significantly increased. Treatment with TG alone significantly increased the expression of pGSK and Act/PKB. Combined TG+STZ treatment tended to reduce the STZ- and TG-induced increase in pGSK expression (p=0.067 and 0.075 by Mann-Whitney U test), while Act/PKB expression remained significantly increased in comparison to the control group. Nonphosphorylated GSK was unchanged after all the treatments. Significant deficits in learning and memory were found in all treatments in comparison to the control group. Conclusions. Our results demonstrate increased hippocampal pGSK levels in one month lasting experimental Alzheimer's disease, supporting the hypothesis of altered brain insulin signalling in this disorder. Unchanged Act/PKB and GSK protein level may point to the disturbances at the level of other insulin-dependent regulators of GSK phoshorylation status. This effect, as well as cognitive deficits could not be blocked by combined treatment of STZ and GLUT2 inhibitor, which prevents peripheral STZ toxicity. Blockade of GLUT2 itself seems to affect brain insulin, as demonstrated at the level of insulin signalling and cognitive behaviour. Supported by DAAD (Germany) and the Croatian Ministry of Science, Technology and Sport (0108253).  0GKOPlŒЁЂЄЌЎАИЙЦЧ; < › œ Ќ ­ Ў ъ ы і ї  ѓчѓоѓчочвЦЛАЅ™ЅАААА‚Аw™Ѕl`lUh ФhњJmH sH h ФhCSЯ5mH sH h ФhCSЯmH sH h ФhЂ2mH sH h ФhG2зmH sH h ФhНTH*mH sH h Фh ФH*mH sH h Фh ФmH sH h ФhНTmH sH h Фh\/emH sH h ФhНT>*mH sH h ФhНT5mH sH hЂt55mH sH h ФhG2з5mH sH h Фh§Gо5mH sH Ш; ­ ъ ы Ю01їїїїїѕэхх$a$gdmг$a$gdњJ$a$gdaУ 1ў 6 7 J T ^ } ˆ ‰ Њ Ћ Ќ Ц   0 2 F H N ^ € ‚ … ‘ • – Џ А Б К Л Ь а х ц љ ћ ќ §     R ž ѕъпдпЩОъГЩЈъ’ъ†ъѕпѕЩЈѕ{ѕ’п’ѕп{’ѕ{ѕ{ѕ{ѕпsпh ФmH sH h Фh`GmH sH h ФhњJ5mH sH h ФhЖmH sH h Фh9mH sH h ФhьcwmH sH h ФhžmH sH h Фh›sjmH sH h ФhшKemH sH h Фh ФmH sH h Фh EкmH sH h ФhњJmH sH h ФhO ЕmH sH -ž    H P x †  Ј Њ к ъ ь ќ ў '6:?HWc{ЎИРЧзсхц&@[cdrŸѕъпѕдѕдЩдѕпѕНъВЩВЇѕЇѕЇŸ”п~пВsп~дВ~п~п~ѕ~В~h Фh ФmH sH h ФhmH sH h ФhS џmH sH h Фho2}mH sH h ФmH sH h Фhіs—mH sH h Фh›sjmH sH h Фh Eк5mH sH h Фh`GmH sH h Фh9mH sH h ФhyISmH sH h Фh EкmH sH h ФhЖmH sH -Ÿ ъђ&KVXop‘Чќ"#'.3;@AMNR_lu‡ЈАЛМНлчєѕъпъдъШъдНдВНЇпЇНœЇН‘п‘ЇдЇ†д{ЇдЇВЇд†œ†œp†h ФhЭ;ŽmH sH h Фh{d•mH sH h Фh^l)mH sH h Фh›sjmH sH h Фh`GmH sH h Фh‰0†mH sH h Фh\/emH sH h ФhљtЩmH sH h ФhшKe5mH sH h ФhT.оmH sH h Фh ФmH sH h ФhшKemH sH h ФhЖmH sH )є  !IJl€‚ЂЉЊДЙУЬЭЮсшщюђ./01ѕъпъѕдпдпЩпОдпдпГЊžЊž’ž’ž†{h ФhžmH sH h Фhž6mH sH h ФhЭ;Ž6mH sH h Фh`G6mH sH hЙ 6mH sH h ФhњJmH sH h Фh ФmH sH h ФhЭ;ŽmH sH h ФhжmH sH h Фh`GmH sH h Фh^l)mH sH h Фhй4mH sH ,1hА‚. АЦA!А‰"А‰#‰$‰%ААФАФ Фœ@@ёџ@ NormalCJ_HaJmHsHtHDA@ђџЁD Default Paragraph FontRi@ѓџГR  Table Normalі4ж l4жaі (k@єџС(No ListFP@ђF mг Body Text 26CJaJmH sH 1 "џџџџШ;­ъыЮ 0 3 ˜0€€˜0€€˜0€€€˜0€€˜0€€x˜0€€˜0€€˜0€€˜0€€3 0 №‹Є ž Ÿє1 1 1 џџ .Ьу.Є!.єL.ЁоФ…ЌўџеЭеœ.“—+,љЎ0ј hpŒ”œЄ ЌДМФ Ь ктMedicinski fakultet, { M Title ўџџџўџџџ !ўџџџ#$%&'()ўџџџ+,-./01ўџџџ§џџџ4ўџџџўџџџўџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџRoot Entryџџџџџџџџ РF0я„VЁоФ6€Data џџџџџџџџџџџџ1TableџџџџWordDocumentџџџџ."SummaryInformation(џџџџџџџџџџџџ"DocumentSummaryInformation8џџџџџџџџ*CompObjџџџџџџџџџџџџjџџџџџџџџџџџџўџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџўџ џџџџ РFMicrosoft Word Document MSWordDocWord.Document.8є9Вq